hotspot -WSS

hotspot

author：leisure time 2025-08-12 09:11:25 - browse：665

A pharmacist hands a box of Wegovy — first opinion coverage from STAT — Bloomberg photo by George Frey

LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of its blockbuster obesity drug Wegovy for new patients in the United States, after massive demand and a supply crunch had led it to limit doses last May.

The announcement that Novo was making more of its lower-dose starter product available as of this month came as the company reported its 2023 earnings, with sales up by 36% and operating profit up 44% at constant exchange rates, driven by enormous sales of Wegovy and Ozempic, the company’s sister drug for diabetes. The company also projected double-digit growth in sales and operating profit for 2024.

“I am pleased to state that we are now enabling more new U.S. patients to initiate treatment by more than doubling the amount of lower-dose strength Wegovy compared to previous months,” Novo CEO Lars Fruergaard Jørgensen said on a call with reporters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： U.K. decision on ALS drug has neurologists, advocates up in arms

WSS

The biotech scorecard for Q3: 15 stock

Researchers test human milk's ability to repair gut microbiome

The biotech scorecard for Q3: 15 stock

Medicare Advantage 2025 payments will dip, Biden administration says

Bird flu in dairy cattle: New measures to control spread to humans

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

explore

hotspot

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Malaria cases in Florida and Texas: Here’s what you need to know

UpToDate has a racism problem: Dr. Stanley Goldfarb

The high cost of giving birth even with insurance

Scientists uncover potential path to treating deadly childhood tumor

Heart attack and stroke risk calculators need revising

Covid silver lining: Unprecedented look at human immune system

Alkermes shareholders re

Insurer loopholes limit power of law against surprise medical bills

explore

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Researchers test human milk's ability to repair gut microbiome

Fatty liver disease was alleviated by Lilly’s ‘triple

How Robert F. Kennedy Jr. distorted vaccine science

Bird flu in dairy cattle: New measures to control spread to humans

Scientific mystery highlights the blind spots in genomics databases

hotspot

explore

focus

knowledge